-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Hepion Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q3 2024.
- Hepion Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
- Hepion Pharmaceuticals, Inc. Depreciation for the twelve months ending September 30, 2024 was $75.9K, a 20.8% decline year-over-year.
- Hepion Pharmaceuticals, Inc. annual Depreciation for 2023 was $100K, unchanged from 2022.
- Hepion Pharmaceuticals, Inc. annual Depreciation for 2022 was $100K, unchanged from 2021.
- Hepion Pharmaceuticals, Inc. annual Depreciation for 2021 was $100K, a 190% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)